120 related articles for article (PubMed ID: 38277853)
1. Trends in enzyme-inducing antiseizure medication use: A retrospective analysis among adults with epilepsy.
Gandelman-Marton R; Theitler J
Epilepsy Behav; 2024 Mar; 152():109662. PubMed ID: 38277853
[TBL] [Abstract][Full Text] [Related]
2. The treatment of epilepsy in younger and older adults: Demographic differences and prescribing patterns of anti-seizure medications in Canada.
Haris A; Bachour K; Hopkins RB; Tarride JE; Keezer MR
Epilepsy Res; 2022 Aug; 184():106941. PubMed ID: 35785633
[TBL] [Abstract][Full Text] [Related]
3. Effects of enzyme-inducing antiseizure medication on vitamin D dosing in adult veterans with epilepsy.
Menninga N; Koukounas Y; Margolis A; Breslow R; Gidal B
Epilepsy Res; 2020 Mar; 161():106287. PubMed ID: 32088519
[TBL] [Abstract][Full Text] [Related]
4. Independent Associations of Incident Epilepsy and Enzyme-Inducing and Non-Enzyme-Inducing Antiseizure Medications With the Development of Osteoporosis.
Josephson CB; Gonzalez-Izquierdo A; Denaxas S; Sajobi TT; Klein KM; Wiebe S
JAMA Neurol; 2023 Aug; 80(8):843-850. PubMed ID: 37306981
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-inducing antiseizure medication utilization in patients with epilepsy and vascular risk factors.
Fox J; Ajinkya S; Lekoubou A
Epilepsy Behav; 2020 Nov; 112():107465. PubMed ID: 32950766
[TBL] [Abstract][Full Text] [Related]
6. Complications associated with the use of enzyme-inducing and non-enzyme-inducing anti-seizure medications in the Japanese population: A retrospective cohort study.
Gao J; Seki T; Usami K; Fan D; Ikeda A; Kawakami K
Epilepsy Behav; 2022 Apr; 129():108610. PubMed ID: 35231856
[TBL] [Abstract][Full Text] [Related]
7. Patterns of psychotropic drug use in veterans with epilepsy: Do drug interactions matter?
Gidal BE; Rehman R; Tran T; Karasov A
Epilepsy Behav; 2023 Aug; 145():109335. PubMed ID: 37429123
[TBL] [Abstract][Full Text] [Related]
8. Association of Enzyme-Inducing Antiseizure Drug Use With Long-term Cardiovascular Disease.
Josephson CB; Wiebe S; Delgado-Garcia G; Gonzalez-Izquierdo A; Denaxas S; Sajobi TT; Lamidi M; Wang M; Keezer MR
JAMA Neurol; 2021 Nov; 78(11):1367-1374. PubMed ID: 34605857
[TBL] [Abstract][Full Text] [Related]
9. First-line levetiracetam versus enzyme-inducing antiseizure medication in glioma patients with epilepsy.
van der Meer PB; Maschio M; Dirven L; Taphoorn MJB; Koekkoek JAF;
Epilepsia; 2023 Jan; 64(1):162-169. PubMed ID: 36380710
[TBL] [Abstract][Full Text] [Related]
10. The effect of anti-seizure medications on lipid values in adults with epilepsy.
Muller AL; Diaz-Arias L; Cervenka MC; McDonald TJW
Epilepsy Behav; 2023 Jul; 144():109260. PubMed ID: 37244221
[TBL] [Abstract][Full Text] [Related]
11. Stroke and Ischemic Heart Disease With Enzyme-inducing Antiseizure Medications: Time to Change Prescribing Habits.
Vossler DG
Epilepsy Curr; 2022; 22(2):120-122. PubMed ID: 35444497
[No Abstract] [Full Text] [Related]
12. PROVE: Retrospective, non-interventional, Phase IV study of perampanel in real-world clinical care of patients with epilepsy.
Wechsler RT; Wheless J; Zafar M; Huesmann GR; Lancman M; Segal E; Chez M; Aboumatar S; Patten A; Salah A; Malhotra M
Epilepsia Open; 2022 Jun; 7(2):293-305. PubMed ID: 34942053
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST).
Lattanzi S; Canafoglia L; Canevini MP; Casciato S; Chiesa V; Dainese F; De Maria G; Didato G; Falcicchio G; Fanella M; Ferlazzo E; Fisco G; Gangitano M; Giallonardo AT; Giorgi FS; La Neve A; Mecarelli O; Montalenti E; Piazza F; Pulitano P; Quarato PP; Ranzato F; Rosati E; Tassi L; Di Bonaventura C;
CNS Drugs; 2021 Dec; 35(12):1289-1301. PubMed ID: 34476770
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double-blind, phase III studies.
Steinhoff BJ; Patten A; Williams B; Malhotra M
Epilepsia; 2020 Feb; 61(2):278-286. PubMed ID: 31944276
[TBL] [Abstract][Full Text] [Related]
15. Antiseizure medication treatment outcomes in new-onset pediatric epilepsy.
Itamura S; Sasaki K; Fujii Y; Okano R
Pediatr Int; 2023; 65(1):e15523. PubMed ID: 36912459
[TBL] [Abstract][Full Text] [Related]
16. Trends in antiseizure medication prescription patterns among all adults, women, and older adults with epilepsy: A German longitudinal analysis from 2008 to 2020.
Hochbaum M; Kienitz R; Rosenow F; Schulz J; Habermehl L; Langenbruch L; Kovac S; Knake S; von Podewils F; von Brauchitsch S; Hamacher M; Strzelczyk A; Willems LM
Epilepsy Behav; 2022 May; 130():108666. PubMed ID: 35339390
[TBL] [Abstract][Full Text] [Related]
17. Greater need for treatment optimization in patients with epilepsy initiating adjunctive therapy: Results of a retrospective claims analysis of antiseizure medication drug load in the United States.
Connor GS; Labiner DM; Schabert VF; Weingarten M; Wade CT; Stern S; Becker DA
Epilepsy Behav; 2024 Mar; 152():109649. PubMed ID: 38277849
[TBL] [Abstract][Full Text] [Related]
18. Prescription trends in anti-seizure medications for adult patients with epilepsy in Japan: A retrospective cohort study using the database of health insurance claims between 2015 and 2019.
Jin K; Obara T; Hirano K; Hirai D; Kiuchi M; Tanaka T; Nakasato N
Epilepsy Behav; 2022 Sep; 134():108841. PubMed ID: 35901657
[TBL] [Abstract][Full Text] [Related]
19. Impact of antiseizure medication with a very long half-life on long term video-EEG monitoring in focal epilepsy.
Hampel KG; Morata-Martínez C; Garcés-Sánchez M; Villanueva V
Seizure; 2024 Feb; 115():100-108. PubMed ID: 38158320
[TBL] [Abstract][Full Text] [Related]
20. Non-discontinuation of antiseizure medication in seizure-free epilepsy patients.
Doerrfuss JI; Hüsing T; Graf L; Ilyas-Feldmann M; Holtkamp M
Eur J Neurol; 2024 Mar; 31(3):e16160. PubMed ID: 38015451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
